Cacciarelli TV et al. |
An analysis of pretransplantation variables associated with long-term allograft outcome in pediatric liver transplant recipients receiving primary tacrolimus (FK506) therapy. |
1999 |
Transplantation |
pmid:10507484
|
Morrissey PE |
Prope tolerance: is it the end or the means? |
2009 |
Transplantation |
pmid:19502973
|
Alloway RR |
Mounting Clinical Evidence With Tacrolimus Generic Products. |
2017 |
Transplantation |
pmid:28749820
|
Prókai à et al. |
Calcineurin-inhibition Results in Upregulation of Local Renin and Subsequent Vascular Endothelial Growth Factor Production in Renal Collecting Ducts. |
2016 |
Transplantation |
pmid:26502369
|
Lykavieris P et al. |
Angioedema in pediatric liver transplant recipients under tacrolimus immunosuppression. |
2003 |
Transplantation |
pmid:12544888
|
Moffatt SD et al. |
Potential for improved therapeutic index of FK506 in liposomal formulation demonstrated in a mouse cardiac allograft model. |
1999 |
Transplantation |
pmid:10342309
|
Woodle ES et al. |
FK506--reversal of humorally mediated cardiac allograft rejection in the presence of preformed anti-class I antibody. |
1993 |
Transplantation |
pmid:7504346
|
Yin DP et al. |
Lewis rat pancreas, but not cardiac xenografts, are resistant to anti-gal antibody mediated hyperacute rejection. |
2001 |
Transplantation |
pmid:11391223
|
Eberhard OK et al. |
How best to use tacrolimus (FK506) for treatment of steroid- and OKT3-resistant rejection after renal transplantation. |
1996 |
Transplantation |
pmid:8629294
|
Bruce DS et al. |
Multicenter survey of daclizumab induction in simultaneous kidney-pancreas transplant recipients. |
2001 |
Transplantation |
pmid:11726823
|
Loucaidou M et al. |
Five-year results of kidney transplantation under tacrolimus-based regimes: the persisting significance of vascular rejection. |
2003 |
Transplantation |
pmid:14557763
|
Muthukumar T et al. |
HIV-infected kidney graft recipients managed with an early corticosteroid withdrawal protocol: clinical outcomes and messenger RNA profiles. |
2013 |
Transplantation |
pmid:23503504
|
King-Biggs MB et al. |
Airway anastomotic dehiscence associated with use of sirolimus immediately after lung transplantation. |
2003 |
Transplantation |
pmid:12792493
|
Hricik DE et al. |
Long-term graft outcomes after steroid withdrawal in African American kidney transplant recipients receiving sirolimus and tacrolimus. |
2007 |
Transplantation |
pmid:17297401
|
Roberts JP et al. |
Reversal of chronic rejection after treatment failure with FK506 and RS61443. |
1993 |
Transplantation |
pmid:7692634
|
Cacciarelli TV et al. |
Oral tacrolimus (FK506) induction therapy in pediatric orthotopic liver transplantation. |
1996 |
Transplantation |
pmid:8610416
|
Jain A et al. |
Comparative long-term evaluation of tacrolimus and cyclosporine in pediatric liver transplantation. |
2000 |
Transplantation |
pmid:10972220
|
Sharif A et al. |
Insulin resistance indexes in renal transplant recipients maintained on tacrolimus immunosuppression. |
2010 |
Transplantation |
pmid:20145524
|
Abu-Qaoud MS et al. |
Lack of relationship between microvascular and macrovascular disease in heart transplant recipients. |
2012 |
Transplantation |
pmid:23044666
|
Kaplan B et al. |
Frequency of hyperkalemia in recipients of simultaneous pancreas and kidney transplants with bladder drainage. |
1996 |
Transplantation |
pmid:8900321
|
Woodward RS et al. |
Renal graft survival and calcineurin inhibitor. |
2005 |
Transplantation |
pmid:16177637
|
Gruber SA et al. |
Initial results of solitary pancreas transplants performed without regard to donor/recipient HLA mismatching. |
2000 |
Transplantation |
pmid:10933170
|
Shapiro R et al. |
Alopecia as a consequence of tacrolimus therapy. |
1998 |
Transplantation |
pmid:9603186
|
Fernandez LA et al. |
The effects of maintenance doses of FK506 versus cyclosporin A on glucose and lipid metabolism after orthotopic liver transplantation. |
1999 |
Transplantation |
pmid:10589951
|
Kadry Z et al. |
Kaposi's sarcoma in liver transplant recipients on FK506. |
1998 |
Transplantation |
pmid:9583882
|
Batten P et al. |
Human T cell responses to human and porcine endothelial cells are highly sensitive to cyclosporin A and FK506 in vitro. |
1999 |
Transplantation |
pmid:10589954
|
Uemura T et al. |
Single dose of alemtuzumab induction with steroid-free maintenance immunosuppression in pancreas transplantation. |
2011 |
Transplantation |
pmid:21841541
|
Jacobson PA et al. |
Novel polymorphisms associated with tacrolimus trough concentrations: results from a multicenter kidney transplant consortium. |
2011 |
Transplantation |
pmid:21206424
|
Ko S et al. |
The enhanced immunosuppressive efficacy of newly developed liposomal FK506 in canine liver transplantation. |
1995 |
Transplantation |
pmid:7539553
|
Fealy MJ et al. |
Association of down-regulation of cytokine activity with rat hind limb allograft survival. |
1995 |
Transplantation |
pmid:7539555
|
Yang H et al. |
Liposomal encapsulation significantly enchances the immunosuppressive effect of tacrolimus in a discordant islet xenotransplant model. |
2002 |
Transplantation |
pmid:11907415
|
St A Nunes FA and Lucey MR |
Searching for a balance when applying immunosuppression after liver transplantation. |
2001 |
Transplantation |
pmid:11258425
|
Opelz G and Döhler B |
Influence of immunosuppressive regimens on graft survival and secondary outcomes after kidney transplantation. |
2009 |
Transplantation |
pmid:19300179
|
Rostambeigi N et al. |
Unique cellular and mitochondrial defects mediate FK506-induced islet β-cell dysfunction. |
2011 |
Transplantation |
pmid:21200364
|
Mikhalski D et al. |
Cold ischemia is a major determinant of acute rejection and renal graft survival in the modern era of immunosuppression. |
2008 |
Transplantation |
pmid:18401260
|
Gibson SW et al. |
Nutritional immunomodulation leads to enhanced allograft survival in combination with cyclosporine A and rapamycin, but not FK506. |
2000 |
Transplantation |
pmid:10852592
|
Ciancio G et al. |
A randomized pilot study of donor stem cell infusion in living-related kidney transplant recipients receiving alemtuzumab. |
2013 |
Transplantation |
pmid:23903014
|
Lerut J et al. |
Anti-CD2 monoclonal antibody and tacrolimus in adult liver transplantation. |
2005 |
Transplantation |
pmid:16314784
|
Komori K et al. |
The role of graft and host accommodation in a hamster-to-rat cardiac transplantation model. |
2008 |
Transplantation |
pmid:18192920
|
Meiser BM et al. |
Tacrolimus or cyclosporine: which is the better partner for mycophenolate mofetil in heart transplant recipients? |
2004 |
Transplantation |
pmid:15446320
|
Uemoto S et al. |
Experience with FK506 in living-related liver transplantation. |
1993 |
Transplantation |
pmid:7679528
|
Murase N et al. |
FK 506 prevents spontaneous diabetes in the BB rat. |
1991 |
Transplant. Proc. |
pmid:1703705
|
Lauzurica R et al. |
Subclinical inflammation in renal transplant recipients: impact of cyclosporine microemulsion versus tacrolimus. |
2007 |
Transplant. Proc. |
pmid:17889127
|
Manzanares C et al. |
Influence of hepatitis C virus infection on FK 506 blood levels in renal transplant patients. |
1998 |
Transplant. Proc. |
pmid:9636513
|
Pérez-Flores I et al. |
Intracellular ATP levels in CD4+ lymphocytes are a risk marker of rejection and infection in renal graft recipients. |
2009 Jul-Aug |
Transplant. Proc. |
pmid:19715845
|
Spinelli GA et al. |
Lipid profile changes during the first year after kidney transplantation: risk factors and influence of the immunosuppressive drug regimen. |
2011 |
Transplant. Proc. |
pmid:22172836
|
Urbizu JM et al. |
Immunosuppression using tacrolimus/mycophenolate versus neoral/mycophenolate following kidney transplantation: a single-center experience. |
2002 |
Transplant. Proc. |
pmid:11959197
|
Mac Guad R et al. |
Effects of CYP3A5 Genetic Polymorphism on the Pharmacokinetics of Tacrolimus in Renal Transplant Recipients. |
|
Transplant. Proc. |
pmid:26915847
|
Staschak S et al. |
A cost comparison of liver transplantation with FK 506 or CyA as the primary immunosuppressive agent. |
1990 |
Transplant. Proc. |
pmid:1689896
|
Zeevi A et al. |
Comparative in vitro studies on the immunosuppressive effects of purine and pyrimidine synthesis inhibitors. |
1993 |
Transplant. Proc. |
pmid:7679843
|
Wakizaka Y et al. |
Xenotransplantation of hamster liver into Gunn rats reserves congenital hyperbilirubinemia. |
1996 |
Transplant. Proc. |
pmid:8623372
|
Chueh SC et al. |
Drug fever caused by mycophenolate mofetil in a renal transplant recipient--a case report. |
2000 |
Transplant. Proc. |
pmid:11120003
|
Ueno T et al. |
Renal dysfunction following adult intestinal transplant under tacrolimus-based immunosuppression. |
2006 Jul-Aug |
Transplant. Proc. |
pmid:16908274
|
Bora F et al. |
Drug interaction between tacrolimus and ertapenem in renal transplantation recipients. |
2012 |
Transplant. Proc. |
pmid:23195020
|
Crespo-Leiro MG |
Calcineurin inhibitors in heart transplantation. |
2005 |
Transplant. Proc. |
pmid:16386614
|
Rucay P et al. |
FK 506 as treatment of late acute rejection in liver transplant patients. |
1995 |
Transplant. Proc. |
pmid:7533354
|
Katz HR et al. |
Mast cell biochemical and functional heterogeneity. |
1991 |
Transplant. Proc. |
pmid:1721308
|
Oppenheimer F |
Steroid withdrawal in renal transplant recipients. |
2000 |
Transplant. Proc. |
pmid:10686314
|
Tamura A et al. |
Combination effect of tacrolimus and FTY720 in liver transplantation in rats. |
1999 |
Transplant. Proc. |
pmid:10578290
|
Florman S et al. |
Conversion of stable liver transplant recipients from a twice-daily Prograf-based regimen to a once-daily modified release tacrolimus-based regimen. |
2005 |
Transplant. Proc. |
pmid:15848672
|
Niederstadt C et al. |
Effect of FK506 on magnesium homeostasis after renal transplantation. |
1997 |
Transplant. Proc. |
pmid:9365709
|
Chen JW et al. |
Ten-year results of a randomised prospective study of FK506 versus cyclosporine in management of primary orthotopic liver transplantation. |
2002 |
Transplant. Proc. |
pmid:12176460
|
Fukuzaki T et al. |
Induction of unresponsiveness to islet allografts with donor spleen cell inoculation followed by a single injection of FK 506. |
1995 |
Transplant. Proc. |
pmid:7533407
|
Rucay P et al. |
FK 506 rescue therapy for refractory acute rejection in five liver recipients. |
1991 |
Transplant. Proc. |
pmid:1721340
|
Mortensen DM et al. |
Calcineurin activity in tacrolimus-treated renal transplant patients early after and 5 years after transplantation. |
2006 |
Transplant. Proc. |
pmid:17098028
|
Loucaidou M et al. |
Late steroid withdrawal for renal transplant recipients on tacrolimus and MMF is safe. |
2005 |
Transplant. Proc. |
pmid:15919469
|
Malyszko J et al. |
A possible role of hepcidin in the pathogenesis of anemia among kidney allograft recipients. |
2009 |
Transplant. Proc. |
pmid:19857675
|
Costa A et al. |
Small bowel myoelectrical activity after transplantation in pigs: motility versus ACR score. |
1997 |
Transplant. Proc. |
pmid:9142281
|
Kitamura M et al. |
Clinical experience of FK 506 for renal allograft transplantation. |
1994 |
Transplant. Proc. |
pmid:7520611
|
Hung CM et al. |
Tacrolimus to rescue refractory hepatic allograft rejection: a collaborative study in Taiwan. |
1998 |
Transplant. Proc. |
pmid:9838572
|
Fung JJ et al. |
Adverse effects associated with the use of FK 506. |
1991 |
Transplant. Proc. |
pmid:1721372
|
Omar G et al. |
FK 506 inhibition of cyclosporine metabolism by human liver microsomes. |
1991 |
Transplant. Proc. |
pmid:1703356
|
Miller J |
Tacrolimus and mycophenolate mofetil in renal transplant recipients: one year results of a multicenter, randomized dose ranging trial. FK506/MMF Dose-Ranging Kidney Transplant Study Group. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083106
|
Busuttil RW and Holt CD |
Tacrolimus (FK506) is superior to cyclosporine in liver transplantation. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123119
|
Cho WH et al. |
Basiliximab does not reduce the early rejection incidence in high-risk kidney recipients under tacrolimus-based immunosuppression. |
2008 |
Transplant. Proc. |
pmid:18790201
|
Kim JD et al. |
Single-Center Experience of ABO-Incompatible Living-Donor Liver Transplantation With a New Simplified Intravenous Immunoglobulin Protocol: A Propensity Score-Matching Analysis. |
2016 |
Transplant. Proc. |
pmid:27320573
|
Weinbroum AA et al. |
Lack of cumulative effect of tacrolimus and low flow on a rat isolated liver. |
2001 |
Transplant. Proc. |
pmid:11543812
|
Jacobs TW et al. |
The effect of FK 506, cyclosporine A, and cyclosporine G on serum 1,25-dihydroxyvitamin D levels. |
1991 |
Transplant. Proc. |
pmid:1721403
|
Yoshimura R et al. |
A comparative study of cyclosporine vs FK 506: role of kidney microsomal cytochrome P-450. |
1992 |
Transplant. Proc. |
pmid:1379755
|
Baruch Y et al. |
Anasarca and hypertrophic cardiomyopathy in a liver transplant patient on FK506: relieved after a switch to Neoral. |
1996 |
Transplant. Proc. |
pmid:8769215
|
Zuckermann A et al. |
Benefit of mycophenolate mofetil in patients with cyclosporine A-induced nephropathy after lung transplantation. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083518
|
Arai K et al. |
Prolonged limb allograft survival with short-term treatment with FK-506 in rats. |
1989 |
Transplant. Proc. |
pmid:2468256
|
Ohdan H et al. |
Prolongation of hamster-to-rat liver xenograft survival by donor bone marrow augmentation. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123589
|
Langrehr JM et al. |
Quadruple versus dual tacrolimus-based induction after liver transplantation: a prospective, randomized trial. |
2001 |
Transplant. Proc. |
pmid:11377549
|
Uber PA et al. |
Steroid weaning in heart transplantation is associated with decreased B-type natriuretic peptide: surrogate evidence for cardiac adaptation. |
2002 |
Transplant. Proc. |
pmid:12176598
|
Wada H et al. |
An attempt to induce tolerance to skin grafts in congenic mice with FK 506. |
1991 |
Transplant. Proc. |
pmid:1721435
|
Ghio L et al. |
Conversion from tacrolimus to cyclosporine for a non-dose-dependent tacrolimus-induced toxicity, a pediatric kidney transplant recipient case report. |
2004 |
Transplant. Proc. |
pmid:15251325
|
Calne R et al. |
Observations about FK-506 in primates. |
1987 |
Transplant. Proc. |
pmid:2445078
|
Halloran PF et al. |
Calcineurin and the biological effect of cyclosporine and tacrolimus. |
1998 |
Transplant. Proc. |
pmid:9723430
|
Renner FC et al. |
The risk of polyomavirus-associated graft nephropathy is increased by a combined suppression of CD8 and CD4 cell-dependent immune effects. |
2013 |
Transplant. Proc. |
pmid:23726630
|
Walgenbach KJ et al. |
Upregulation of basic fibroblast growth factor during chronic rejection of rat intestinal allografts and its downregulation by FK 506. |
1998 |
Transplant. Proc. |
pmid:9745501
|
Laftavi MR et al. |
The role of antibiotic prophylaxis in the new era of immunosuppression. |
2011 |
Transplant. Proc. |
pmid:21440753
|
Jordan ML et al. |
Steroid withdrawal for pancreas transplants under tacrolimus immunosuppression. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267456
|
Konno O et al. |
Early Outcomes of Living-Donor Kidney Transplantation With Immunosuppression Therapy Induction With Tacrolimus Extended-Release: A Comparison With Cyclosporine. |
2018 |
Transplant. Proc. |
pmid:30316378
|
Li S et al. |
Intrathymic inoculation of donor bone marrow at the time of transplantation plus a short course of tacrolimus induce long-term acceptance to rat lung allografts. |
1998 |
Transplant. Proc. |
pmid:9636431
|
Pinho-Apezzato ML et al. |
Multiple clinical presentations of lymphoproliferative disorders in pediatric liver transplant recipients: a single-center experience. |
2010 |
Transplant. Proc. |
pmid:20620519
|
Suarez Benjumea A et al. |
Hepatitis C Virus in Kidney Transplant Recipients: A Problem on the Path to Eradication. |
2016 |
Transplant. Proc. |
pmid:27932111
|
Rathi M et al. |
Conversion from tacrolimus to cyclosporine in patients with new-onset diabetes after renal transplant: an open-label randomized prospective pilot study. |
2015 |
Transplant. Proc. |
pmid:26036543
|
Henley SE et al. |
Lipids following pancreas transplantation in recipients receiving FK 506. |
1995 |
Transplant. Proc. |
pmid:8539809
|
Pridöhl O et al. |
Low-dose immunosuppression with FK 506 and sirolimus after liver transplantation: 1-year results. |
2001 Nov-Dec |
Transplant. Proc. |
pmid:11750384
|